Evidence map›Paper›PMID 31278206›Full record

GuidelineGut2019

British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.

Matthew Banks, David Graham, Marnix Jansen, Takuji Gotoda, Sergio Coda, Massimiliano di Pietro, Noriya Uedo, Pradeep Bhandari, D Mark Pritchard, Ernst J Kuipers and 5 more

3 registry-linked trialsOpen access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in Gut, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 321 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
321citing papers in PubMed, 10 pooled it
57.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04114006 completednot on this map

Initial Analysis of Wide-area Transepithelial Sampling for the Detection of Gastric Neoplasia

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2019 to 2023Enrolled120ConditionsGastric Cancer
NCT05657080 unknown statusnot on this mapstarted 2023, after this paper: background citation

An Investigation on Cytosponge and Molecular Biomarkers to Identify Patients With Gastric Intestinal Metaplasia (GIM)

TypeobservationalSponsorUniversity of CambridgeRan2023 to 2024Enrolled226ConditionsGastric Cancer, Gastric Intestinal Metaplasia, Gastric AtrophyArmsCytosponge-TFF3
NCT06273384 unknown statusnot on this mapstarted 2024, after this paper: background citation

Diagnostic Performance of Current Infection Marker (CIM) for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding

TypeobservationalSponsorMahidol UniversityRan2024 to 2024Enrolled135ConditionsHelicobacter Pylori Infection, Peptic Ulcer Hemorrhage
3 · Its place in the literature

Who cites it

321 citing papers in PubMed, 10 syntheses or guidelines pooled it, 612 citations in OpenAlex.

  1. [Evidence-Based Guidelines for the Diagnosis and Treatment ofThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026
    Guideline
  2. Guideline
  3. Pooled it
  4. Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
    Pooled it
  5. Pooled it
  6. Guideline
  7. First regional consensus on the management ofWorld journal of gastroenterology · 2025
    Guideline
  8. Guideline
  9. Pooled it
  10. Clinical Practice Guideline for Gastritis in Korea.Journal of Korean medical science · 2023
    Guideline
  11. Trial
  12. Trial
  13. Trial
  14. Diagnosing and grading gastric atrophy and intestinal metaplasia using semi-supervised deep learning on pathological images: development and validation study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Trial
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

261 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 6 countries.

Matthew BanksUniversity College London Hospital, University College London Hospitals NHS Foundation Trust, London, UK.ORCID 0000-0002-9137-2779
David GrahamUniversity College London Hospital, University College London Hospitals NHS Foundation Trust, London, UK.
Marnix JansenDepartment of Histopathology, University College London, London, UK.ORCID 0000-0003-0645-564X
Takuji GotodaGastroenterology, Nihon University School of Medicine Graduate School of Medicine, Itabashi-ku, Tokyo, Japan.
Sergio CodaEndoscopy, Inhealth Group, London, UK.
Massimiliano di PietroMRC Cancer Unit, University of Cambridge, Cambridge, UK.
Noriya UedoDepartment of Gastrointestinal Oncology, Endoscopic Training and Learning Center, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Pradeep BhandariGastroenterology, Portsmouth, Portsmouth, UK.
D Mark PritchardInstitute of Translational Medicine, University of Liverpool, Liverpool, UK.
Ernst J KuipersErasmus University Medical Center, Rotterdam, Netherlands.
Manuel Rodriguez-JustoDepartment of Histopathology, University College London, London, UK.
Marco R NovelliDepartment of Histopathology, University College London, London, UK.
Krish RagunathNottingham Digestive Diseases Centre, Nottingham University Hospital, Nottingham, UK.
Neil ShepherdGloucestershire Cellular Pathology Laboratory, Cheltenham General Hospital, Cheltenham, Gloucestershire, UK.
Mario Dinis-RibeiroGastroenterology, IPO Porto, Porto, Portugal.
University College London · GBUniversity College Hospital · GBAmerican Society for Gastrointestinal Endoscopy · USCheltenham General Hospital · GBErasmus MC · NLIPO Porto · PTNihon University · JPNIHR Nottingham Digestive Diseases Biomedical Research Unit · GBUnidad de Cirugía Artroscópica · ESUniversity Gastroenterology · USUniversity of Cambridge · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include

Indexed as

AdenocarcinomaBiomarkers, TumorDisease ManagementDisease ProgressionEarly Detection of CancerEvidence-Based MedicineGastritis, AtrophicGastroscopyHelicobacter InfectionsHelicobacter pyloriHumansPrecancerous ConditionsRisk AssessmentStomach NeoplasmsBiomarkers, Tumorendoscopygastric adenocarcinomagastric pre-cancergastritishelicobacter pylori-gastritis

Identifiers

PMID31278206
PMCPMC6709778
OpenAlexW2953923712

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.